Philadelphia Chromosome Positive Recruiting Phase 1 Trials for Cyclophosphamide (DB00531)

Also known as: Philadelphia chromosome positive

IndicationStatusPhase
DBCOND0046287 (Philadelphia Chromosome Positive)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03241940CD19/CD22 Chimeric Antigen Receptor T Cells and Chemotherapy in Treating Children or Young Adults With Recurrent or Refractory CD19 Positive B Acute Lymphoblastic LeukemiaTreatment
NCT03233854CD19/CD22 Chimeric Antigen Receptor T Cells and Chemotherapy in Treating Patients With Recurrent or Refractory CD19 Positive Diffuse Large B-Cell Lymphoma or B Acute Lymphoblastic LeukemiaTreatment